Gossamer Bio
Developing seralutinib for hypertension
- B2B
About Gossamer Bio
San Diego-based biopharmaceutical company developing seralutinib for pulmonary arterial hypertension, with a focus on enhancing the lives of those affected
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- san diego, california, United States
- Founded
- 2017
- Revenue
- $48.5MFY2025, publicly reported
- Website
- gossamerbio.com
Gossamer Bio at a glance
Gossamer Bio is a B2B company in the Biotechnology Research industry, headquartered in san diego, california, United States.
Gossamer Bio was founded in 2017.
Gossamer Bio has 51–250 employees.
Gossamer Bio's revenue is $48.5M (FY2025, publicly reported).
Selling to companies like Gossamer Bio?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies